Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Olema Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- −11 vs. Q1 2025
- Shares held
- 70.5M
- +4.63M (+7.0%) vs. Q1 2025
- Total value
- $300.5M
- +$52.5M (+21.2%) vs. Q1 2025
- New holders
- 18
- 57 more added
- Sold out
- 29
- 27 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Candriam Luxembourg S.C.A. | 850,454 | $3.62M | 0.02% | −630.0% | Reduced |
| State Street Corp | 1,051,967 | $4.48M | 0.00% | +186,411+21.5% | Added |
| Ameriprise Financial Inc | 1,172,863 | $5.00M | 0.00% | +773,064+193.4% | Added |
| Dimensional Fund Advisors LP | 1,207,150 | $5.14M | 0.00% | −112,029−8.5% | Reduced |
| Millennium Management LLC | 1,271,090 | $5.41M | 0.00% | +292,242+29.9% | Added |
| Geode Capital Management, LLC | 1,326,123 | $5.65M | 0.00% | +242,997+22.4% | Added |
| UBS Group AG | 1,412,099 | $6.02M | 0.00% | +260,952+22.7% | Added |
| Morgan Stanley | 1,437,407 | $6.12M | 0.00% | +985,716+218.2% | Added |
| Vivo Capital, LLC | 1,505,862 | $6.41M | 0.66% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,708,134 | $7.28M | 0.01% | −164,494−8.8% | Reduced |
| Pictet Asset Management Holding SA | 1,879,013 | $8.00M | 0.01% | 00.0% | Unchanged |
| Lightspeed Management Company, L.L.C. | 1,930,894 | $8.23M | 3.44% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,378,762 | $10.1M | 1.76% | −551,684−18.8% | Reduced |
| Franklin Resources Inc | 3,011,969 | $12.8M | 0.00% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,022,784 | $12.9M | 0.01% | +3,022,784 | New |
| Logos Global Management LP | 3,208,875 | $13.7M | 1.83% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,266,999 | $13.9M | 0.00% | +395,386+13.8% | Added |
| Deep Track Capital, LP | 3,442,833 | $14.7M | 0.47% | 00.0% | Unchanged |
| Woodline Partners LP | 3,505,893 | $14.9M | 0.08% | +2,027,986+137.2% | Added |
| BlackRock, Inc. | 4,605,109 | $19.6M | 0.00% | +782,767+20.5% | Added |
| BVF Inc | 5,295,893 | $22.6M | 0.81% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 6,764,172 | $28.8M | 1.23% | +23,000+0.3% | Added |
| Bain Capital Life Sciences Investors, LLC | 6,843,954 | $29.2M | 3.65% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,441,690−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −191,994−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −138,552−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −113,018−100.0% | Sold out |
| Dana Investment Advisors, Inc. | 0 | $0 | 0.00% | −112,954−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −93,669−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −87,705−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −68,974−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −57,824−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −46,699−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −46,510−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −25,125−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −23,932−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −21,741−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −20,026−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −20,020−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −14,193−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −13,874−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −13,499−100.0% | Sold out |
| Pitcairn Co | 0 | $0 | 0.00% | −12,532−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −12,396−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −10,882−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −8,572−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −1,248−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −484−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −249−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −227−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −87−100.0% | Sold out |